Results 101 to 110 of about 8,988 (194)

The Effects of Surgical Androgen Deprivation Therapy for Advanced Prostate Cancer on Peripapillary Retinal Nerve Fiber Layer Thickness. [PDF]

Eurasian J Med
Uzun F, Fındık H, Kaim M.
europepmc   +1 more source

From Mechanism to Medicine: Peptide-Based Approaches for Cancer Diagnosis and Therapy. [PDF]

Biomolecules
Gouveia MJ, Campanhã J, Barbosa F, Vale N.   +3 more
europepmc   +1 more source

Deciphering the 3D Structural Characterization of Gonadotropin-Releasing Hormone in <i>Tenualosa ilisha</i> Using Homology Modeling, Molecular Dynamics, and Docking Approaches. [PDF]

Int J Mol Sci
Panda SP, Das BK, Gadnayak A, Nandy SK, Kumar V, Pradhan SP, Raut SS, Chakrabarty R, Kunui A, Sahoo AK.   +9 more
europepmc   +1 more source

Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents. [PDF]

Cancer Biol Med
Zhao J, Chen J, Sun G, Shen P, Zeng H.
europepmc   +1 more source

Thymus Degeneration in Women and the Influence of Female Sexual Hormones on Thymic Epithelial Cells. [PDF]

Int J Mol Sci
Zhou M, Shu Y, Gao J.
europepmc   +1 more source

Bifocal <i>β</i>-hCG-secreting CNS Germinoma in a 13-Year-Old Boy: Clinical-Biochemical Pubertal Discordance and Long-Term Outcome. [PDF]

Case Rep Pediatr
Nicolescu CR, Doulet ST, Bazus L, Stephan JL.   +3 more
europepmc   +1 more source

Use of Relugolix for the Prevention of Impending Oliguria and Progressive Renal Failure in a Suspected Case of Prostate Carcinoma. [PDF]

Cureus
Kumar P, Prem P, Raut A, Ahmad S, Singh S.   +4 more
europepmc   +1 more source

Luteinizing Hormone-Releasing Hormone (LHRH)-Conjugated Cancer Drug Delivery from Magnetite Nanoparticle-Modified Microporous Poly-Di-Methyl-Siloxane (PDMS) Systems for the Targeted Treatment of Triple Negative Breast Cancer Cells. [PDF]

J Funct Biomater
Eluu SC, Obayemi JD, Yiporo D, Salifu AA, Oko AO, Onwudiwe K, Aina T, Oparah JC, Ezeala CC, Etinosa PO, Osafo SA, Ugwu MC, Esimone CO, Soboyejo WO.   +13 more
europepmc   +1 more source

Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy. [PDF]

Int J Nanomedicine
Lei SY, Qin H, Liu S, Sheng J.
europepmc   +1 more source

Functional assessment in patients with castration-resistant prostate cancer treated with darolutamide: results from the DaroAcT study. [PDF]

Oncologist
Beer TM, George DJ, Shore ND, Winters-Stone K, Wefel JS, Verholen F, Srinivasan S, Ortiz J, Morgans AK.   +8 more
europepmc   +1 more source